Skip to main content
Jaszianne Tolbert, MD, Pediatric Hematology & Oncology, Kansas City, MO

Jaszianne Ashtrelle Tolbert MD


Physician

Join to view full profile
  • 2401 Gillham RdKansas City, MO 64108

  • Phone+1 816-234-3000

  • Fax+1 816-302-9894

Dr. Tolbert is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Children’s Mercy Hospital
    Children’s Mercy HospitalFellowship, Pediatric Hematology/Oncology, 2012 - 2015
  • University of Arkansas for Medical Sciences (UAMS) College of Medicine
    University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 2009 - 2012
  • LSU School of Medicine in Shreveport
    LSU School of Medicine in ShreveportClass of 2009
  • Xavier University of Louisiana
    Xavier University of LouisianaBS, Biology/Chemistry, 1998 - 2002

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2012 - 2020
  • KS State Medical License
    KS State Medical License 2015 - 2019

Publications & Presentations

PubMed

Journal Articles

  • The Creating Hope Act: What Is Old Is New Again  
    Tolbert J, Goldman J, Kaufmann R, Abdel-Rahman S, Pediatric Health, Medicine and Therapeutics, 1/1/2014
  • Common Acquired Causes of Thrombosis in Children  
    Tolbert J, Carpenter S, Current Problems in Pediatric and Adolescent Health Care, 1/1/2013

Abstracts/Posters

  • Pharmacokinetics (PK) of Two 6-Mercaptopurine (6-MP) Liquid Formulations in Children with Acute Lymphoblastic Leukemia (ALL).
    Tolbert JA, Kearns GL, Abdel-Rahman SM, Weir SJ, Leeder JS, Neville KA, Clinical Pharmacology and Therapeutics, Annual Meeting of the American Society of Clinical Pharmacology and Therapeutics (ASCPT), New Orleans, LA, 1/1/2015
  • Gemtuzumab Ozogamicin (GO) And Toxic Mortality (TM) In Children and Adolescents with Acute Myeloid Leukemia (AML) Enrolled on Children's Oncology Group (COG) Trial AAM...
    Tolbert J, Sung L, Aplenc R, Alonzo T, Wang Y, Gerbing R, Mesinchi S, Gamis A, Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/1/2015
  • Pharmacokinetics and Relative Oral Bioequivalence of Two 6-Mercaptopurine (6-MP) Liquid Formulations in Children with Acute Lymphoblastic Leukemia (ALL).
    Tolbert JA, August, KJ, Abdel-Rahman SM, Weir SJ, Leeder JS, Neville KA, CMH Annual Research Days, Children's Mercy Hospital, Kansas City, MO, 1/1/2015

Lectures

  • Hepatoblastoma: Case report and Current Diagnostic and Surgical Guidelines 
    Kansas City, MO - 1/1/2015
  • Rhabdomyosarcoma: Current Diagnostic and Treatment Guidelines 
    Kansas City, MO - 1/1/2015
  • Antiphospholipid Antibody Syndrome: Current Diagnostic and Treatment Guidelines 
    Kansas City, MO - 1/1/2015

Press Mentions

  • Web Extra: Inside 'Inside Pediatrics'
    Web Extra: Inside 'Inside Pediatrics'February 11th, 2019
  • Improving Pediatric Hematology Oncology Outcomes Through Precision Medicine and Experimental Therapeutics
    Improving Pediatric Hematology Oncology Outcomes Through Precision Medicine and Experimental TherapeuticsFebruary 6th, 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: